Cerebral is an online psychiatry and therapy platform offering medication management, counseling, and care coordination for mental health conditions including anxiety, depression, ADHD, and insomnia. Its subscription model bundles provider access with prescription delivery.
Cerebral operates in a crowded mental health telehealth market alongside BetterHelp, Talkspace, and Brightside. Regulatory scrutiny around controlled substance prescribing has impacted the company, while demand for accessible mental health care continues to grow post-pandemic.
Massive therapist network focused on counseling rather than medication management. Scale advantage in matching users with providers.
Pioneered asynchronous text therapy with strong enterprise partnerships. Insurance integrations broaden access beyond out-of-pocket payment.
Clinical outcome focus with measurement-based care. Combines therapy and medication management with published efficacy data.
Cerebral has faced scrutiny over controlled substance prescribing practices, particularly for ADHD stimulants. Regulatory changes could limit its ability to prescribe certain medications via telehealth.
Expanding insurance acceptance would dramatically increase the addressable market. Talkspace's insurance partnerships demonstrate the model, but payer integration adds clinical documentation and compliance burdens.
Psychiatrist shortages limit scaling of medication management services. Platforms that rely on prescribers face supply-side constraints that therapy-only platforms avoid.
Cerebral competes with BetterHelp (therapy), Talkspace (text-based therapy and psychiatry), Brightside (evidence-based psychiatry), and Done (ADHD-focused). Traditional psychiatric practices with telehealth offerings also compete.
Cerebral focuses on psychiatry and medication management, while BetterHelp is primarily a therapy platform without prescribing capabilities. Cerebral serves users who need medication, while BetterHelp targets those seeking counseling.
Cerebral employs licensed psychiatrists and therapists. However, the company has faced regulatory scrutiny regarding prescribing practices. Users should verify their provider's credentials and discuss treatment plans thoroughly.